Source: Journal of Molecular Structure. Unidades: EACH, IQSC
Subjects: QUALIDADE DE VIDA, NEUROLOGIA
ABNT
CHIARI, Laise Pellegrini Alencar; HONÓRIO, Káthia Maria; SILVA, Alberico Borges Ferreira da; et al. Drug design of new sigma-1 antagonists against neuropathic pain: A QSAR study using partial least squares and artificial neural networks. Journal of Molecular Structure, Amsterdam, Elsevier, v. 1223, p. 129156, 2021. Disponível em: < https://doi.org/10.1016/j.molstruc.2020.129156 > DOI: 10.1016/j.molstruc.2020.129156.APA
Chiari, L. P. A., Honório, K. M., Silva, A. B. F. da, Silva, A. P. da, Oliveira, A. A., & Lipinski, C. F. (2021). Drug design of new sigma-1 antagonists against neuropathic pain: A QSAR study using partial least squares and artificial neural networks. Journal of Molecular Structure, 1223, 129156. doi:10.1016/j.molstruc.2020.129156NLM
Chiari LPA, Honório KM, Silva ABF da, Silva AP da, Oliveira AA, Lipinski CF. Drug design of new sigma-1 antagonists against neuropathic pain: A QSAR study using partial least squares and artificial neural networks [Internet]. Journal of Molecular Structure. 2021 ; 1223 129156.Available from: https://doi.org/10.1016/j.molstruc.2020.129156Vancouver
Chiari LPA, Honório KM, Silva ABF da, Silva AP da, Oliveira AA, Lipinski CF. Drug design of new sigma-1 antagonists against neuropathic pain: A QSAR study using partial least squares and artificial neural networks [Internet]. Journal of Molecular Structure. 2021 ; 1223 129156.Available from: https://doi.org/10.1016/j.molstruc.2020.129156